The "ABCDE" Score as a Five-step Vascular Ultrasound Examination in Heart Failure

NCT03771209 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 480

Last updated 2018-12-11

No results posted yet for this study

Summary

Heart failure (HF) is a clinical syndrome caused by structural and/or functional cardiac abnormalities, resulting in a reduced cardiac output and/or elevated intra-cardiac pressures at rest or during stress. It is the leading cause of hospitalization in Internal Medicine departments.

This study aims at exploring evidence of the importance of ultrasound in HF both for hospitalized patients and in the follow up. Ultrasound may be used as a recovery monitoring instrument at the bedside and also as a global cardiovascular assessment tool for these patients.

HF represents an exciting opportunity to create an integrative ultrasound approach in Internal Medicine/Geriatric departments.The Authors plan a five-step ultrasound examination to evaluate and monitor HF patients during hospitalization and follow-up. They call this examination: the "ABCDE" score. It includes the evaluations of A, the Ankle-brachial index (ABI), B, the B-lines, C, the Carotid intima media thickness (CIMT), D, the Diameter of the abdominal aorta and of the inferior cave vein and E, the echocardiographic assessment of the ejection fraction.This score represent an integrative ultrasound approach in Internal Medicine/Geriatric departments.

Conditions

Interventions

DIAGNOSTIC_TEST

ultrasound examination

ultrasound assessment

Sponsors & Collaborators

  • University of Palermo

    collaborator OTHER
  • University Of Perugia

    collaborator OTHER
  • IRCCS Sacro Cuore Don Calabria di Negrar

    collaborator OTHER
  • Azienda Ospedaliera Universitaria Integrata Verona

    lead OTHER

Principal Investigators

  • CHIARA MOZZINI, MD,PhD · Universita di Verona

  • DOMENICO GIRELLI, MD,PhD · Universita di Verona

  • MAURIZIO SORESI, MD,PhD · University of Palermo

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-04-26
Primary Completion
2022-04-26
Completion
2022-04-26

Countries

  • Italy

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03771209 on ClinicalTrials.gov